Personal Activity Intelligence (PAI) Pilot
Launched by OHIO UNIVERSITY · Nov 12, 2018
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
This is a pilot project to evaluate the feasibility of a larger study to evaluate the effectiveness of Personal Activity Intelligence (PAI) score in patients with chronic disease, as an adjunct to lifestyle medical therapy.
The PAI score is a proprietary formula developed by PAI Health (PH) to aid physical fitness. A PAI score calculation uses biometrics obtained via a device that measures heart rate and steps. For this study, Mio Slice, a commercial wrist worn device will be utilized to obtain data which will be linked to a smart phone. Data from the smart phone app will be accessed by PA...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients who are seen by the PI in his lifestyle medicine practice at Muntean Health Care.
- • Participants must own a smart phone and feel comfortable managing apps on their smart phone.
- • Participants must be willing and able to register online with PAI Health (PH)
- • Participants must be willing to wear a wrist device around the clock, except when charging or bathing for 12 weeks.
- * Participants must have at least one of the following diagnoses:
- • overweight / obesity
- • diabetes or prediabetes
- • hypertension or pre-hypertension
- • abnormal lipids
- • cardiovascular disease
- Exclusion Criteria:
- • Patients with angina or poor exercise tolerance, based on the evaluation by the PI, will be excluded from the study.
About Ohio University
Ohio University is a leading research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a strong commitment to improving patient outcomes, the university leverages its extensive resources and interdisciplinary expertise to conduct rigorous research across various medical fields. Ohio University collaborates with healthcare professionals, researchers, and community partners to ensure that clinical trials are designed with the highest ethical standards and scientific integrity. Through these efforts, the institution aims to contribute valuable insights to the medical community and enhance the quality of care for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Athens, Ohio, United States
Patients applied
Trial Officials
David S Drozek, DO
Principal Investigator
Ohio University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials